Narcolepsy is characterized by excessive sleepiness and abnormal manifestations of rapid eye movement (REM) sleep. Neurochemical studies of human and canine narcolepsy have demonstrated disturbed monoaminerglc and cholinergic function and suggest that deficits of noradrenaline availability m specific brain regions may account for much of its disordered pathophys1ology. Genetic susceptibility to narcolepsy is closely linked to a specific region of the major histocompatibiHty complex on chromosome 6 and an important d1?ection for future research will be to unravel the relationship between this gene region and the neurochemical abnormalities of narcolepsy.
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Narcolepsy is characterized by excessive sleepiness and abnormal manifestations of rapid eye movement (REM) sleep. Neurochemical studies of human and canine narcolepsy have demonstrated disturbed monoaminerglc and cholinergic function and suggest that deficits of noradrenaline availability m specific brain regions may account for much of its disordered pathophys1ology. Genetic susceptibility to narcolepsy is closely linked to a specific region of the major histocompatibiHty complex on chromosome 6 and an important d1?ection for future research will be to unravel the relationship between this gene region and the neurochemical abnormalities of narcolepsy.
Although narcolepsy was first described more than 100 years ago, its pathophysiologic link to REM sleep was not recognized until the 1960s and its frequent association with a specific region of chromosome 6 has been known for less than ten years. This review provides an overview of the clinical syndrome and a discussion of current concepts of the genetics and neurochemistry of narcolepsy.
Symptoms of narcolepsy usually become apparent between 15 and 35 years of age and continue throughout life. Although the onset may be attributed to stress, head trauma, or minor infections, these apparent precipitants may be just coincidental. Sleepiness, the most disabling symptom, is most evident during boring, sedentary situations and is partially alleviated by stimulation; in these respects, it is similar to what is experienced by normal people after sleep deprivation. However, narcoleptic sleepiness differs in that it is virtually continuous and cannot be fully relieved by any amount of nighttime or daytime sleep. Sleep 'attacks', or episodes of spontaneous sleep, are the culmination of a progressive increase in sleepiness to overwhelming proportions. Excessive sleepiness is more characteristic than increased sleep, and periods of daytime sleep are usually brief.
Other common symptoms include cataplexy, sleep paralysis, hypnagogic hallucinations, and disturbed nocturnal sleep. Cataplexy, a brief episode of muscular weakness unassociated with altered consciousness, is usually brought on by excitement or emotion. Severe attacks cause complete paralysis, while milder episodes lead to partial weakness involving facial, ocular, or limb muscles. Sleep paralysis refers to episodes of inability to move during sleep onset or upon awakening, and hypnagogic hallucinations, which may accompany sleep paralysis, are dream-like images that differ from dreams in that awareness of surroundings is partially preserved.
The frequent occurrence of rapid eye movement (REM) sleep at the onset of sleep is one of the most striking features of narcolepsy and the discovery of this abnormality provided the first clue to its pathogenesis. REM sleep is characterized by cortical activation with desynchronized EEG, increased brain metabolism, skeletal muscle atonia, rapid conjugate eye movements, and dreams. Substantial evidence suggests that the intrusion of REM sleep atonia into wakefulness is the cause of cataplexy and sleep paralysis and that hypnagogic hallucinations are due to the intrusion of dream imagery into the waking state. Thus, dissociated manifestations of REM sleep appear to be responsible for many of the symptoms of narcolepsy.
However, narcolepsy is not just a disorder of REM sleep. Frequent nocturnal awakenings that offset the increase in daytime sleep, daytime non-REM sleep episodes, and periods of ambiguous sleep that combine physiological features of REM and non-REM sleep are evidence of impaired sleep/wake regulation and reflect the indistinct boundaries between sleep states I.
Neurochemical links between narcolepsy and REM sleep
The frequent occurrence of sleep onset REM periods and the link between narcoleptic symptoms and dissociated manifestations of REM sleep have led researchers to investigate brain structures and neurotransmitters involved in the control of REM sleep. Neuroanatomical studies using brainstem transections have demonstrated that the pons is the most critical site for the generation of REM sleep: REM sleep signs occur caudally but not rostrally with transections above the pons while the reverse is true with transections below the pons. Lesion studies suggest that regions of the pontine tegmentum involving the nucleus reticularis pontis oralis and the area just rostral to the locus coeruleus are essential components of the brain systems that permit REM sleep to occur. Single unit recording studies have identified neurons in these regions that fire selectively during REM sleep (Fig. 1) , REM-on cells, while cells that are selectively silent during REM sleep, REM-off cells, are also located in these areas and in the closely adjacent locus coeruleus and dorsal raphE nucleus 2,3 (Fig. 2) . The pontine regions responsible for REM sleep are modulated by diencephalic and forebrain structures and send projections to neurons of the spinal cord, oculomotor nuclei, thalamus, and cortex that mediate muscle atonia, rapid eye movements, and cortical activation.
Although the neurochemistry of REM sleep has not been characterized fully, it is clear that acetylcholine plays an essential role. For example, systemic administration or local injection of cholinergic agonists into selected areas of the pontine tegmenturn facilitates the appearance of REM sleep 4. Numerous neurons with immunoreactivity for cholineacetyltransferase (CHAT) are present in the area of the locus coeruleus and peri-locus coeruleus and many pontine REM-on cells appear to be cholinergic or cholinoceptive or both 2'4.
Compelling evidence suggests that most of the
